Publication | Closed Access

Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells

MedicineImmunologyImmunoeditingImmune Checkpoint InhibitorAnti-cancer AgentAntibody-dependent Lymphocyte CytotoxicityProstaglandin ProductionImmunotherapyPharmacologyTumor Target CellsCancer ResearchTumor MicroenvironmentTumor Biology